Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v5-EN
Language English English
Date Updated 2020-02-25 2020-02-24
Drug Identification Number 02242119 02242119
Brand name AGGRENOX AGGRENOX
Common or Proper name Aggrenox 200/25mg Aggrenox 200/25mg
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients ACETYLSALICYLIC ACID DIPYRIDAMOLE ACETYLSALICYLIC ACID DIPYRIDAMOLE
Strength(s) 25MG 200MG 25MG 200MG
Dosage form(s) CAPSULE (IMMEDIATE AND EXTENDED RELEASE) CAPSULE (IMMEDIATE AND EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 60's 60's
ATC code B01AC B01AC
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-08-30 2019-08-30
Actual discontinuation date 2020-02-24 2020-02-24
Remaining supply date 2019-04-30 2019-04-30
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments